Neferine suppresses osteoclast differentiation through suppressing NF‐κB signal pathway but not MAPKs and promote osteogenesis
- 24 May 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (12) , 22960-22971
Abstract
Osteoporosis is an ageing disease characterized by elevated osteoclastic bone resorption resulting in bone loss, decrease bone strength, and elevated incidence of fractures. Neferine, a natural compound isolated from the traditional Chinese medicine Nelumbo nucifera (Lotus), has been reported exhibit anti‐inflammatory, antioxidant, and anticancer properties. However, its effect on bone remains to be determined. Here we showed that Neferine inhibits RANKL‐induced osteoclast formation in a dose‐ and time‐dependent manner. Furthermore, Neferine also demonstrated antiresorptive properties by effectively ameliorating the bone resorptive activity of mature osteoclasts. Mechanistically, Neferine suppressed RANKL‐induced activation of NF‐κB signaling pathway. This in turn hindered the induction and activation of NFATc1 resulting in downregulation of osteoclast marker genes closely related to differentiation, fusion as well as bone resorption. Interestingly, we found Neferine enhanced the differentiation and bone mineralization activity of MC3T3‐E1 preosteoblast cells. Finally, mice treated with Neferine was protected against ovariectomy (OVX)‐induced bone loss. The Neferine treatment improved bone volume following ovariectomy and also exhibited less TRAP‐positive osteoclasts on bone surface. Collectively our data provide promising evidence that Neferine could be a potential therapeutic application for against osteolytic bone conditions such as osteoporosis.Keywords
Funding Information
- National Natural Science Foundation of China (81272059)
This publication has 20 references indexed in Scilit:
- Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix qualityBone, 2017
- Neferine prevents NF‐κB translocation and protects muscle cells from oxidative stress and apoptosis induced by hypoxiaBioFactors, 2016
- Efficacy and safety of currently marketed anti-osteoporosis medicationsBest Practice & Research Clinical Endocrinology & Metabolism, 2014
- Neferine prevented hyperglycemia-induced endothelial cell apoptosis through suppressing ROS/Akt/NF-κB signalEndocrine, 2014
- Neferine, an alkaloid from lotus seed embryo, inhibits human lung cancer cell growth by MAPK activation and cell cycle arrestBioFactors, 2013
- NF-κB signaling and bone resorptionOsteoporosis International, 2013
- Neferine enhances insulin sensitivity in insulin resistant ratsJournal of Ethnopharmacology, 2009
- NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factorArthritis Research & Therapy, 2007
- Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasisNature, 2004
- Osteoclast differentiation and activationNature, 2003